These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 19109834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
    Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA.
    Liver Transpl; 2008 Oct; 14(10):1491-7. PubMed ID: 18825708
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatitis C therapy before and after liver transplantation.
    Terrault NA.
    Liver Transpl; 2008 Oct; 14 Suppl 2():S58-66. PubMed ID: 18825697
    [Abstract] [Full Text] [Related]

  • 6. Management of liver transplant recipients with recurrent hepatitis C.
    McCashland TM.
    Curr Opin Organ Transplant; 2009 Jun; 14(3):221-4. PubMed ID: 19444107
    [Abstract] [Full Text] [Related]

  • 7. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
    Cescon M, Grazi GL, Cucchetti A, Vetrone G, Ravaioli M, Ercolani G, Morelli MC, Piscaglia F, Tamè M, Pinna AD.
    Liver Transpl; 2009 Jul; 15(7):782-9. PubMed ID: 19562715
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatitis C.
    Burra P.
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic management of recurrent hepatitis C after liver transplantation.
    Teixeira R, Menezes EG, Schiano TD.
    Liver Int; 2007 Apr; 27(3):302-12. PubMed ID: 17355450
    [Abstract] [Full Text] [Related]

  • 11. Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients.
    Tanaka T, Selzner N, Therapondos G, Renner EL, Lilly LB.
    Transpl Int; 2013 Jan; 26(1):42-9. PubMed ID: 23137287
    [Abstract] [Full Text] [Related]

  • 12. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 13. Scarce influence of corticosteroid boluses on long-term viral load and liver histology in transplanted patients with recurrent hepatitis C.
    Barcena R, Oton E, Barreales M, Castillo M, Blesa C.
    Transplant Proc; 2006 Oct; 38(8):2502-4. PubMed ID: 17097981
    [Abstract] [Full Text] [Related]

  • 14. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA, Feldstein AE, McCullough AJ, Miller C, Aucejo F, Yerian L, Lopez R, Zein NN.
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Liver transplantation for hepatitis C virus related liver disease.
    Gee I, Alexander G.
    Postgrad Med J; 2005 Dec; 81(962):765-71. PubMed ID: 16344300
    [Abstract] [Full Text] [Related]

  • 19. Is early antiviral therapy for recurrent hepatitis C after liver transplantation superior to later treatment? The answer is no.
    Roche B, Samuel D.
    Liver Transpl; 2011 May; 17(5):488-91. PubMed ID: 21455930
    [No Abstract] [Full Text] [Related]

  • 20. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W, Al-Nakib W.
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.